Progressive stages of NAFLD lead to an increased level of ROS, free radicals, and a low level of SOD, catalase, and other antioxidant enzymes (Balakrishnan et al. 2021). This evidence concerns the gene SOD1 and metabolic dysfunction-associated steatotic liver disease.